Emergent BioSolutions Inc. (EBS)
Largest Insider Buys in Sector
EBS Stock Price History Chart
EBS Stock Performance
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, it is developing AP003, a Naloxone multidose nasal spray; AP007, a sustained release Nalmefene injection for treatment of opioid use disorder; AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; COVID-HIG for the treatment of SARS-CoV2; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, the company provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Insider Activity of Emergent BioSolutions Inc.
Over the last 12 months, insiders at Emergent BioSolutions Inc. have bought $0 and sold $75,831 worth of Emergent BioSolutions Inc. stock.
On average, over the past 5 years, insiders at Emergent BioSolutions Inc. have bought $112,380 and sold $13.9M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,000 shares for transaction amount of $112,380 was made by LINDAHL RICHARD S (EVP, Chief Financial Officer) on 2021‑11‑15.
List of Insider Buy and Sell Transactions, Emergent BioSolutions Inc.
| 2024-06-04 | Sale | Zoon Kathryn C | director | 10,000 0.021% | $6.11 | $61,100 | +14.30% | |
| 2024-05-29 | Sale | Zoon Kathryn C | director | 1,830 0.0035% | $4.61 | $8,436 | +34.16% | |
| 2024-05-21 | Sale | Zoon Kathryn C | director | 1,089 0.0023% | $5.78 | $6,294 | +17.76% | |
| 2023-06-02 | Sale | Zoon Kathryn C | director | 1,830 0.0037% | $8.35 | $15,281 | -68.08% | |
| 2023-05-25 | Sale | Zoon Kathryn C | director | 1,700 0.0035% | $8.38 | $14,246 | -67.30% | |
| 2022-11-25 | Sale | Richard Ronald | director | 1,912 0.0038% | $11.94 | $22,829 | -29.50% | |
| 2022-06-09 | Sale | Zoon Kathryn C | 1,173 0.0023% | $31.52 | $36,973 | -57.24% | ||
| 2022-05-24 | Sale | Zoon Kathryn C | 1,996 0.0043% | $35.53 | $70,918 | -58.06% | ||
| 2021-11-15 | LINDAHL RICHARD S | EVP, Chief Financial Officer | 3,000 0.0055% | $37.46 | $112,380 | -11.87% | ||
| 2021-05-25 | Sale | Zoon Kathryn C | director | 3,139 0.0058% | $56.48 | $177,291 | -17.33% | |
| 2021-03-04 | Sale | Bailey Sue | director | 8,168 0.0156% | $92.37 | $754,478 | -36.39% | |
| 2021-03-01 | Sale | Havey Adam | EVP, Business Operations | 37,279 0.068% | $99.30 | $3.7M | -42.76% | |
| 2021-02-08 | Sale | Kramer Robert | President and CEO | 13,000 0.0237% | $120.03 | $1.56M | -51.36% | |
| 2021-01-21 | Sale | Kramer Robert | President and CEO | 21,900 0.0411% | $110.03 | $2.41M | -44.59% | |
| 2021-01-20 | Sale | Kramer Robert | President and CEO | 2,232 0.0043% | $110.00 | $245,520 | -43.44% | |
| 2021-01-15 | Sale | Kramer Robert | President and CEO | 19,026 0.0356% | $106.01 | $2.02M | -42.45% | |
| 2020-11-10 | Sale | El-Hibri Fuad | Chairman | 19,391 0.0371% | $88.21 | $1.71M | -27.09% | |
| 2020-11-09 | Sale | El-Hibri Fuad | Chairman | 20,000 0.0403% | $95.26 | $1.91M | -28.70% | |
| 2020-11-03 | Sale | El-Hibri Fuad | Chairman | 20,000 0.0371% | $90.74 | $1.81M | -30.76% | |
| 2020-11-02 | Sale | El-Hibri Fuad | Chairman | 20,000 0.0377% | $90.44 | $1.81M | -29.35% |
Insider Historical Profitability
| Zoon Kathryn C | director | 54482 0.0963% | $6.56 | 0 | 20 | |
| Intervac, L.L.C. | 10 percent owner | 6136794 11.8278% | $6.56 | 0 | 22 | |
| Biologika, L.L.C. | Member 13(d) group owning >10% | 1399764 2.6979% | $6.56 | 0 | 2 | |
| Michigan Biologic Products, Inc. | Member 13(d) group owning >10% | 1269390 2.4466% | $6.56 | 0 | 39 | |
| El-Hibri Fuad | Chairman | 1123988 2.1663% | $6.56 | 0 | 143 | |
| Abdun-Nabi Daniel | CEO | 142617 0.2749% | $6.56 | 2 | 48 | +48.31% |
| Kramer Robert | President and CEO | 139210 0.2683% | $6.56 | 0 | 34 | |
| SULLIVAN LOUIS W | director | 42762 0.0824% | $6.56 | 0 | 8 | |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | 39919 0.0769% | $6.56 | 1 | 0 | <0.0001% |
| Havey Adam | EVP, Business Operations | 38190 0.0736% | $6.56 | 1 | 24 | +10.39% |
| White Marvin L | director | 30300 0.0584% | $6.56 | 0 | 1 | |
| JOULWAN GEORGE A | director | 26771 0.0516% | $6.56 | 0 | 7 | |
| Labinger Barry | EVP, Biosciences Div. | 25182 0.0485% | $6.56 | 0 | 3 | |
| Harsanyi Zsolt | director | 24579 0.0474% | $6.56 | 0 | 18 | |
| Bailey Sue | director | 24427 0.0471% | $6.56 | 0 | 12 | |
| Elsey R Don | Chief Financial Officer | 22199 0.0428% | $6.56 | 1 | 9 | <0.0001% |
| Richard Ronald | director | 19837 0.0382% | $6.56 | 0 | 25 | |
| Kirk Sean | EVP, Manufacturing & Tech Ops | 12571 0.0242% | $6.56 | 0 | 1 | |
| Hauer Jerome M | director | 10188 0.0196% | $6.56 | 0 | 16 | |
| Keese Kyle | SVP, Mfg Ops | 9070 0.0175% | $6.56 | 0 | 27 | |
| LOCKHART STEPHEN | SVP Product Development | 6980 0.0135% | $6.56 | 0 | 3 | |
| Zink Thomas | SVP & CMO | 990 0.0019% | $6.56 | 2 | 0 | <0.0001% |
| Esposito Denise | CLO | 500 0.001% | $6.56 | 0 | 2 | |
| Gibellini Mauro | SVP, Corporate Dev. | 0 0% | $6.56 | 0 | 1 | |
| Chatfield Steven | EVP, BioSciences | 0 0% | $6.56 | 0 | 3 |
Institutional Investor Ownership
| BlackRock | $17.86M | 13.47 | 7.06M | -24.89% | -$5.92M | <0.0001 | |
| Charles Schwab | $10.5M | 7.92 | 4.15M | +44.45% | +$3.23M | <0.01 | |
| The Vanguard Group | $8.63M | 6.51 | 3.41M | +14.69% | +$1.11M | <0.0001 | |
| Avidity Partners Management Lp | $4.83M | 3.64 | 1.91M | New | +$4.83M | 0.18 | |
| Morgan Stanley | $3.27M | 2.47 | 1.29M | +4.72% | +$147,615.42 | <0.0001 | |
| Geode Capital Management | $2.84M | 2.14 | 1.12M | +2.19% | +$60,666.50 | <0.0001 | |
| Two Sigma Advisers LP | $2.72M | 2.05 | 1.07M | -1.28% | -$35,167.00 | 0.01 | |
| State Street | $2.68M | 2.02 | 1.06M | -0.5% | -$13,555.74 | <0.0001 | |
| AQR Capital | $2.6M | 2.01 | 1.05M | +104.84% | +$1.33M | <0.01 | |
| Two Sigma | $2.56M | 1.93 | 1.01M | -2.41% | -$63,325.90 | <0.01 | |
| Millennium Management LLC | $2.26M | 1.71 | 894,158 | -57.33% | -$3.04M | <0.01 | |
| Invesco | $2.26M | 1.7 | 892,879 | +205.91% | +$1.52M | <0.0001 | |
| Renaissance Technologies | $2.25M | 1.7 | 891,300 | +62.85% | +$870,324.24 | <0.01 | |
| Assenagon Asset Management S.A. | $2.12M | 1.6 | 839,414 | +0.6% | +$12,756.26 | 0.01 | |
| Fuller & Thaler Asset Management, Inc. | $1.96M | 1.48 | 775,625 | New | +$1.96M | 0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $1.79M | 1.35 | 706,235 | +235.58% | +$1.25M | <0.01 | |
| Bridgeway Capital Management | $1.5M | 1.13 | 591,933 | -3.98% | -$62,045.70 | 0.03 | |
| Values First Advisors, Inc. | $1.19M | 0.9 | 470,087 | +52.68% | +$410,353.31 | 0.26 | |
| Palisade Capital Management | $1.17M | 0.88 | 461,648 | +2.5% | +$28,427.07 | 0.04 | |
| Northern Trust | $1.13M | 0.85 | 447,600 | -0.86% | -$9,821.46 | <0.0001 | |
| D. E. Shaw & Co. | $1.05M | 0.8 | 416,664 | -64.88% | -$1.95M | <0.01 | |
| Bank of America | $1.01M | 0.76 | 398,063 | -6.03% | -$64,563.04 | <0.0001 | |
| Dimensional Fund Advisors | $967,078.00 | 0.73 | 382,244 | -41.93% | -$698,219.77 | <0.0001 | |
| Marshall Wace | $782,963.00 | 0.59 | 309,472 | +295.86% | +$585,172.95 | <0.01 | |
| Goldman Sachs | $741,171.00 | 0.56 | 292,953 | -61.04% | -$1.16M | <0.0001 | |
| UBS | $723,679.00 | 0.55 | 286,039 | +40.8% | +$209,683.97 | <0.0001 | |
| Prudential Financial | $720,569.00 | 0.54 | 284,810 | +55.29% | +$256,541.89 | <0.01 | |
| JPMorgan Chase | $692,056.00 | 0.52 | 273,540 | +436.81% | +$563,134.83 | <0.0001 | |
| American Century Investments | $654,491.00 | 0.49 | 258,692 | +181.33% | +$421,847.29 | <0.0001 | |
| Hilltop Holdings Inc. | $522,948.00 | 0.39 | 206,699 | -2.58% | -$13,839.09 | 0.06 | |
| Los Angeles Capital Management LLC | $490,797.00 | 0.37 | 193,991 | +20.09% | +$82,123.76 | <0.01 | |
| BNY Mellon | $430,174.00 | 0.32 | 170,029 | -4.04% | -$18,109.77 | <0.0001 | |
| Cetera Advisors LLC | $428,372.00 | 0.32 | 169,317 | New | +$428,372.00 | <0.01 | |
| Deutsche Bank | $403,335.00 | 0.3 | 159,421 | -0.65% | -$2,641.32 | <0.0001 | |
| New York State Common Retirement Fund | $388,000.00 | 0.29 | 153,404 | 0% | +$0 | <0.01 | |
| Aristeia Capital | $366,314.00 | 0.28 | 144,788 | New | +$366,314.00 | 0.02 | |
| Jane Street Capital | $311,635.00 | 0.24 | 123,176 | -50.13% | -$313,317.45 | <0.0001 | |
| Susquehanna Fundamental Investments Llc | $300,177.00 | 0.23 | 118,647 | New | +$300,177.00 | 0.01 | |
| BB&T | $296,430.00 | 0.22 | 117,166 | +3.08% | +$8,855.00 | <0.0001 | |
| SeaCrest Investment Management, LLC | $242,880.00 | 0.18 | 96,000 | New | +$242,880.00 | 0.03 | |
| RhumbLine Advisers | $221,470.00 | 0.17 | 87,544 | +2.63% | +$5,671.84 | <0.0001 | |
| Citadel Advisors LLC | $210,167.00 | 0.16 | 83,070 | +10.92% | +$20,685.27 | <0.0001 | |
| HSBC | $163,005.00 | 0.12 | 64,429 | -52.85% | -$182,736.42 | <0.0001 | |
| SG Americas Securities, LLC | $149,000.00 | 0.11 | 58,721 | -11.04% | -$18,497.81 | <0.01 | |
| Nuveen | $142,189.00 | 0.11 | 56,201 | 0% | +$0 | <0.0001 | |
| AllianceBernstein | $136,620.00 | 0.1 | 54,000 | -10.69% | -$16,353.92 | <0.0001 | |
| Cubist Systematic Strategies | $104,712.00 | 0.08 | 41,388 | -91.78% | -$1.17M | <0.01 | |
| State Of Wyoming | $103,214.00 | 0.08 | 40,796 | -11.13% | -$12,930.84 | 0.01 | |
| Barclays | $97,000.00 | 0.07 | 38,204 | -72.63% | -$257,431.87 | <0.0001 | |
| Walleye Capital | $78,430.00 | 0.06 | 31,000 | -88.5% | -$603,885.70 | <0.0001 |